Canadian HIV Pregnancy Planning Guidelines

Journal of Obstetrics and Gynaecology Canada

Volumn 34, Issue 6, 2012, Pages 575-590

  Loutfy, Mona R ^a   Margolese, Shari ^a   Money, Deborah M ^a   Gysler, Mathias ^a   Hamilton, Scot ^a   Yudin, Mark H ^a  

^a NONE   (Canada)

Author keywords

Fertility; HIV; Insemination; Pregnancy; Transmission

Indexed keywords

ANTIRETROVIRUS AGENT;

ANTIVIRAL THERAPY; ARTICLE; CANADA; CHILD HEALTH; COUNSELING; EGG DONATION; FAMILY HEALTH; FERTILITY; FERTILIZATION IN VITRO; HEALTH CARE ACCESS; HEALTH CARE NEED; HEALTH CARE PLANNING; HEALTH SERVICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN RIGHTS; INFECTION CONTROL; INFERTILITY; INTRAUTERINE INSEMINATION; MEDICAL ETHICS; MEDICOLEGAL ASPECT; MENTAL HEALTH; PRACTICE GUIDELINE; REPRODUCTIVE PROCEDURE; SEXUAL BEHAVIOR; SEXUAL TRANSMISSION; SOCIAL PSYCHOLOGY; SPERM DONOR; SPERM WASHING; UNPLANNED PREGNANCY; VIRUS TRANSMISSION; DISEASE TRANSMISSION; FAMILY PLANNING; FEMALE; MALE; PREGNANCY; VERTICAL TRANSMISSION;

CANADA; COUNSELING; FAMILY PLANNING SERVICES; FEMALE; HIV INFECTIONS; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; INFERTILITY; MALE; PREGNANCY;

EID: 84871906547     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)35274-4     Document Type: Article

References (80)

1. Palella F.J., Baker R.K., Moorman A.C., Chmiel J.S., Wood K.C., Brooks J.T., et al. HIV Outpatient Study Investigators. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr 2006, 43:27-34.
2. Mocroft A., Ledergerber B., Katlama C., Kirk O., Reiss P., d'Arminio Monforte A., et al. EuroSIDA study group. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet 2003, 362(93777):22-29.
3. The Antiretroviral Therapy Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet 2008, 372(9635):293-299.
4. Public Health Agency of Canada. HIV and AIDS in Canada. Surveillance report to December 31, 2007. Ottawa: Surveillance and Risk Assessment Division, Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada 2008. Available at: . Accessed April 25, 2011. http://www.phac-aspc.gc.ca/aids-sida/publication/survreport/2007/surveillance:2007_10-eng.php.
5. Public Health Agency of Canada. HIV and AIDS in Canada. Surveillance Report to December 31, 2008. Surveillance and Risk Assessment Division, Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada; 2009. Available at: . Accessed April 25 2011. http://www.phac-aspc.gc.ca/aids-sida/publication/survreport/2008/dec/pdf/survrepdec08.pdf.
6. Tharao W., Logie C., James L., Loutfy M. "These are some of the things we need": women living with HIV discuss issues in their daily lives as research priorities 2011.
7. Ogilvie G.S., Palepu A., Remple V.P., Maan E., Heath K., MacDonald G., et al. Fertility intentions of women of reproductive age living with HIV in British Columbia 2007, 21:583-588. AIDS, Canada, Suppl 1.
8. Loutfy M.R., Hart T.A., Mohammed S.S., Su D., Ralph E.D., Walmsley S.L., et al. Ontario HIV Fertility Research Team.Fertility desires and intentions of HIV-positive women of reproductive age in Ontario, Canada: a crosssectional study. PLoS ONE 2009, 4(12):7925.
9. Oladapo O.T., Daniel O.J., Odusoga O.L., Ayoola-Sotubo O. Fertility desires and intentions of HIV-positive patients at a suburban specialist center. J Natl Med Assoc 2005, 97:1672-1681.
10. Nattabi B., Li J., Thompson S.C., Orach C.G., Earnest J. A systematic review of factors influencing fertility desires and intentions among people living with HIV/AIDS: implications for policy and service delivery. AIDS Behav 2009, 13(5):949-968.
11. Semprini A.E., Levi-Setti P., Bozzo M., Ravizza M., Taglioretti A., Sulpizoo P., et al. Insemination of HIV-negative women with processed semen of HIV-positive partners. Lancet 1992, 340:1317-1319.
12. Sauer M.V., Wang J.G., Douglas N.C., Nakhuda G.S., Vardhana P., Jovanovic V., et al. Providing fertility care to men seropositive for human immunodeficiency virus: reviewing 10 years of experience and 420 consecutive cycles of in vitro fertilization and intracytoplasmic sperm injection. Fertil Steril 2009, 91(6):2455-2460.
13. Yudin M.H., Shapiro H.M., Loutfy M.R. Access to infertility services in Canada for HIV-positive individuals and couples: a cross-sectional study. Reprod Health 2010, 7:7. 10.1186/1742-4755-7-7.
14. Newmeyer T., Tecnmer S.N., Jaworsky D., Chihrin S., Gough K., Rachlis A., et al. Case series of fertility treatment in HIV-discordant couples (male positive, female negative): the Ontario experience. PLoS ONE 2011, 6(9):e24853.
15. Loutfy M., Rouboud J., Wong J., Yudin M., Diong C., Blitz S., et al. Ontario HIV Fertility Research Team. High prevalence of unintended pregnancies in HIV-positive women of reproductive age in Ontario, Canada: a retrospective study. HIV Med 2012, 13(2):107-117.
16. Wilcher R., Cates W. Reproductive choices for women with HIV. Bull World Health Organ 2009, 87(11):833-839.
17. O'Bryan T., Jadavji T., Kim J., Gill M.J. An avoidable transmission of HIV from mother to child. CMAJ 2011, 183:690-692.
18. Burdge D.R., Money D.M., Forbes J.C., Walmsley S.L., Smaill F.M., Boucher M., et al. Canadian HIV Trials Network Working Group on Vertical HIV Transmission Canadian consensus guidelines for the management of pregnant HIV-positive women: putting recommendations into practice. CMAJ 2003, 168(13):1683-1688. Revised: June 24, 2003.
19. Canadian Fertility and Andrology Society [website] 2011, Available at, Accessed June 10. http://www.cfas.ca.
20. Public Health Agency of Canada. What is fetal alcohol spectrum disorder (FASD)? 2012, Available at, Accessed April 16. http://www.phac-aspc.gc.ca/hp-ps/dca-dea/prog-ini/fasd-etcaf/publications/fs-fi_01-eng.php.
21. Public Health Agency of Canada. The sensible guide to a healthy pregnancy 2011, Available at, Accessed April 19. http://www.phac-aspc.gc.ca/hp-gs/guide-eng.php.
22. The Society of Obstetricians and Gynaecologists of Canada. Clinical Practice Guidelines 2011, Available at, Accessed October 6. http://www.sogc.org/guidelines/index_e.asp.
23. Britton J.R. Pre-discharge anxiety among mothers of well newborns: prevalence and correlates. Acta Paediatrica 2005, 94:1771-1776.
24. Britton J.R. Maternal anxiety: course and antecedents during the early postpartum period. Depress Anxiety 2008, 25:793-800.
25. Clinton J.F., Kelber S.T. Stress and coping in fathers of newborns: comparisons of planned versus unplanned pregnancy. Int J Nurs Stud 1993, 30(5):437-443.
26. Bell E., Mthembu P., O'Sullivan S. Sexual and reproductive health services and HIV testing: perspectives and experiences of women and men living with HIV and AIDS. Reprod Health Matters 2007, 15(Suppl 29):113-135.
27. Nduna M., Farlane L. Women living with HIV in South Africa and their concerns about fertility. AIDS Behav 2009, 13(Suppl 1):62-65.
28. Bharat S., Mahendra V. Meeting the sexual and reproductive heath needs of people living with HIV: challenges for health providers. Reprod Health Matters 2007, 15(Suppl 29):93-112.
29. Bartell S. On becoming a mother: the psychological journey. Int J Childbirth Educ 2005, 20(1):28-30.
30. Clement S., Sikorski J., Wilson J., Das S. Planning antenatal services to meet women's psychological needs. British Journal of Midwifery 1997, 5(5):298-302.
31. Deave T., Johnson D., Ingram J. Transition to parenthood: the needs of parents in pregnancy and early parenthood X. Transition to parenthood: the needs of parents in pregnancy and early parenthood. BMC Pregnancy Childbirth 2008, 8(30):1-11.
32. Blaney N. Psychosocial and behavioral correlates of depression among HIV-infected pregnant women. AIDS Patient Care STDS 2004, 18(7):405-406.
33. Larrabee K., Monga M., Eriksen N., Helfgott A. Quality of life assessment in pregnant women with the human immunodeficiency virus. Obstet Gynecol 1996, 88(6):1016-1020.
34. Clinton J.F., Kelber S.T. Stress and coping in fathers of newborns: comparisons of planned versus unplanned pregnancy. Int J Nurs Stud 1993, 30(5):437-443.
35. Greening L. And-how was it for you, dad?. Community Pract 2006, 79(6):184-187.
36. Matthey S., Barnett B., Ungerer J., Waters B. Paternal and maternal depressed mood during the transition to parenthood. J Affect Disord 2000, 60:75-85.
37. Ramchandani P., Stein A., Evans J., O'Connor T.G. Paternal depression in the postnatal period and child development: a prospective population study. Lancet 2005, 365:2201-2205.
38. Medley A., Garcia-Moreno C., McGill S., Maman S. Rates, barriers and outcomes of HIV serostatus disclosure among women in developing countries: implications for prevention of mother-to-child transmission programmes. Bull World Health Organ 2004, 82:299-307.
39. Cuerrier R.v. [1998] 2 S.C.R. 371 2012, Available at, Accessed April 16. http://www.canlii.org/en/ca/scc/doc/1998/1998canlii796/1998canlii796.html.
40. Symington A. Criminalization confusion and concerns: the decade s ince the Cuerrier decision. HIV/AIDS Policy and Review, Canadian HIV/AIDS Legal Network 2009, 14(1):1-10.
41. Vernazza P., Hirschel B., Bernasconi E., Flepp M. Les Personnes seropositives ne souffrant d'aucune autre MST et suivant un traitement antiretroviral efficace ne transmettent pas le VIH par voie sexuelle. Bulletin des Medecins Suisses 2008, 89(5):165-169.
42. United Nations AIDS. Criminalization of HIV transmission. UNAIDS Policy Brief 2008.
43. Priest L. Mother avoiding AZT. The Globe and Mail April, 2006.
44. Williams H., Watkins C., Risby J. Reproductive decision-making and determinants of contraceptive use in HIV-infected women. Clin Obstet Gynecol 1996, 39(2):333-343.
45. United Nations Entity for Gender Equality and the Empowerment of Women. Convention on the elimination of all forms of discrimination against women 1979, 1. Article 16.
46. Tubiana R. Extremely low risk of MTCT of HIV in women starting HAART before pregnancy: French Perinatal Cohort, ANRS EPF C01/11 2011, February 27 to March 2, Available at, Boston, Massachusetts, Accessed June 14,2011. http://www.retroconference.org/2011/Abstracts/41451.htm.
47. Angel J.B., Hu Y.W., Kravcik S., Tsui R., Lee K.H., Barbour J., et al. Virological evaluation of the 'Ottawa case' indicates no evidence for HIV-1 superinfection. AIDS 2004, 18(2):331-334.
48. Angel J.B., Kravcik S., Balaskas E., Yen P., Badley A.D., Cameron D.W., et al. Documentation of HIV-1 superinfection and acceleration of disease progression February 2, 2000, San Francisco CA.
49. Blackard J.T., Cohen D.E., Mayer K.H. Human immunodeficiency virus superinfection and recombination: current state of knowledge and potential clinical consequences. Clin Infect Dis 2002, 34(8):1108-1114.
50. The United States Centers for Disease Control and Prevention. Interim guidance: preexposure prophylaxis for the prevention of HIV infection in men who have sex with men. MMWR Morb Mortal Wkly Rep 2011, 60(03):60-68. Available at, Accessed April 14,2011. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6003a1.htm.
51. Grant R.M., Lama J.R., Anderson P.L., McMahan V., Liu A.Y., Vargas L., et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 2010, 2587-2599.
52. The United States Centers for Disease Control and Prevention. Results of FEM-PrEP clinical trial examining pre-exposure prophylaxis (PrEP) for HIV prevention among heterosexual women 2011, Available at, Accessed April 14,2011. http://www.cdc.gov/hiv/prep/femprep.htm.
53. Barreiro P., Castilla J.A., Labarga P., Soriano V. Is natural conception a valid option for HIV-serodiscordant couples?. Hum Reprod 2007, 22(9):2353-2358.
54. Barreiro P., del Romero J., Leal M., Hernando V., Asencio R., de Mendoza C., et al. Spanish HIV-Discordant Study Group. Natural pregnancies in HIV-serodiscordant couples receiving successful antiretroviral therapy. J Acquir Immune Defic Syndr 2006, 43(3):324-326.
55. Melo M.G., Santos B.R., De Cassia Lira R., Varella I.S., Turella M.L., Rocha T.M., et al. Sexual transmission of HIV-1 among serodiscordant couples in Porto Alegre, southern Brazil. Sex Transm Dis 2008, 35(11):912-915.
56. Hart C.E., Lennox J.L., Pratt-Palmore M., Wright T.C., Schinazi R.F., Evans-Strickfaden T. Correlation of human immunodeficiency virus type 1 RNA levels in blood and the female genital tract. J Infect Dis 1999, 179(4):871-882.
57. Public Health Agency of Canada. HIV/AIDS Epi Updates, December 2007. Available at: http://www.phac-aspc.gc.ca/aids-sida/publication/index-eng.php. Accessed March 21, 2012.
58. Quinn T.C., Wawer M.J., Sewankambo N., Serwadda D., Li C., Wabwire-Mangen F., et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000, 342(13):921-929.
59. Fiore J.R., Suligoia B., Saracinob A., Stefanob M.D., Bugarinia R., Leperac A., et al. Correlates of HIV-1 shedding in cervicovaginal secretions and effects of antiretroviral therapies. AIDS 2003, 17(15):2169-2176.
60. Anglemyer A., Rutherford G.W., Baggaley R.C., Egger M., Siegfried N. Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples. Cochrane Database Syst Rev 2011, 8. CD009153.
61. Liuzzi G., Chirianni A., Clementi M., Bagnarelli P., Valenza A., Cataldo P.T., et al. Analysis of HIV-1 load in blood, semen and saliva: evidence for different viral compartments in a cross-sectional and longitudinal study. AIDS 1996, 10:51-56.
62. Coombs R.W., Speck C.E., Hughes J.P., Lee W., Sampoleo R., Ross S.O., et al. Association between culturable human immunodeficiency virus type 1 (HIV-1) in semen and HIV-1 RNA levels in semen and blood: evidence for compartmentalization of HIV-1 between semen and blood. J Infect Dis 1998, 177:320-330.
63. Vitorino R.L., Grinsztejn B.G., de Andrade C.A., Hokerberg Y.H., de Souza C.T., Friedman R.K., et al. Systematic review of the effectiveness and safety of assisted reproduction techniques in couples serodiscordant for human immunodeficiency virus where the man is positive. Fertil Steril 2011, 95:1684-1690.
64. Al-Khan A., Colon J., Palta V., Bardeguez A. Assisted reproductive technology for men and women infected with human immunodeficiency virus type 1. Clin Infect Dis 2003, 36(2):195-200.
65. Bagasra O., Farzadegan H., Seshamma T., Oakes J.W., Saah A., Pomerantz R.J. Detection of HIV-1 proviral DNA in sperm from HIV-1-infected men. AIDS 1994, 8(12):1669-1674.
66. Baker H.W., Mijch A., Garland S., Crowe S., Dunne M., Edgar D., et al. Use of assisted reproductive technology to reduce the risk of transmission of HIV in discordant couples wishing to have their own children where the male partner is seropositive with an undetectable viral load. J Med Ethics 2003, 29(6):315-320.
67. Bujan L., Hollander L., Coudert M., Gilling-Smith C., Vucetich A., Guibert J., et al. CREAThE network. Safety and efficacy of sperm washing in HIV-1-serodiscordant couples where the male is infected: results from the European CREAThE network. AIDS 2007, 21(14):1909-1914.
68. Bujan L., Pasquier C., Labeyrie E., Lanusse-Crousse P., Morucci M., Daudin M. Insemination with isolated and virologically tested spermatozoa is a safe way for human immunodeficiency type 1 virus- serodiscordant couples with an infected male partner to have a child. Fertil Steril 2004, 82(84):857-862.
69. Bujan L., Sergerie M., Kiffer N., Moinard N., Seguela G., Mercadier B., et al. Good efficiency of intrauterine insemination programme for serodiscordant couples with HIV-1 infected male partner: a retrospective comparative study. Eur J Obstet Gynecol Reprod Biol 2007, 135(1):76-82.
70. Barreiro P., Duerr A., Beckerman K., Soriano V. Reproductive options for HIV serodiscordant couples. AIDS Rev 2006, 8(3):158-170.
71. Garrido N., Gil-Salom M., Martmez-Jabaloyas J.M., Meseguer M. First report of the absence of viral load in testicular sperm samples obtained from men with hepatitis C and HIV after washing and their subsequent use. Fertil Steril 2009, 92(3):1012-1015.
72. Garrido N., Meseguer M., Bellver J., Remoh J., Simon C., Pellicer A. Report of the results of a 2 year programme of sperm wash and ICSI treatment for human immunodeficiency virus and hepatitis C virus serodiscordant couples. Hum Reprod 2004, 19(11):2581-2586.
73. Savasi V., Ferrazzi E., Lanzani C., Oneta M., Parrilla B., Persico T. Safety of sperm washing and ART outcome in 741 HIV-1-serodiscordant couples. Hum Reprod 2007, 22(3):772-777.
74. Kim L.U., Johnson M.R., Barton S., Nelson M.R., Sontag G., Smith J.R., et al. Evaluation of sperm washing as a potential method of reducing HIV transmission in HIV-discordant couples wishing to have children. AIDS 1999, 13(6):645-651.
75. Lasheeb A.S., King J., Ball J.K., Curran R., Barratt C.L., Afnan M., et al. Semen characteristics in HIV-1 positive men and the effect of semen washing. Genitourin Med 1997, 73(4):303-305.
76. Hanabusa H., Kuji N., Kato S., Tagami H., Kaneko S., Tanaka H., et al. An evaluation of semen processing methods for eliminating HIV-1. AIDS 2000, 14(11):1611-1616.
77. Kashima K., Takakuwa K., Suzuki M., Makino M., Kaneko S., Kato S., et al. Studies of assisted reproduction techniques (ART) for HIV-1-discordant couples using washed sperm and the nested PCR method: a comparison of the pregnancy rates in HIV-1-discordant couples and control couples. Jpn J Infect Dis 2009, 62(3):173-176.
78. Loutradis D., Drakakis P., Kallianidis K., Patsoula E., Bletsa R., Michalas S. Birth of two infants who were seronegative for human immunodeficiency virus type 1 (HIV-1) after intracytoplasmic injection of sperm from HIV-1-seropositive men. Fertil Steril 2001, 75(1):210-212.
79. Adoption Council of Canada. Adoption in Canada 2012, Available at, Accessed April 12.2012. http://www.adoption.ca/adoption-in-canada.
80. Woolf S.H., Battista R.N., Angerson G.M., Logan A.G., Eel W. Canadian Task Force on Preventive Health Care. New grades for recommendations from the Canadian Task Force on Preventive Health Care. CMAJ 2003, 169:207-208.